Abnormal vaginal flora may lead to preterm birth

Article

Researchers studied data on 759 low-risk women who were between 9 and 16 weeks pregnant to investigate whether bacterial vaginosis (BV), Aerobic vaginitis (AV), and abnormal vaginal flora (AVF) in the first trimester increased the risk for preterm birth.

Yes, according to a recent study from Belgium.

Researchers studied data on 759 low-risk women who were between 9 and 16 weeks pregnant to investigate whether bacterial vaginosis (BV), aerobic vaginitis (AV), and abnormal vaginal flora (AVF) in the first trimester increased the risk for preterm birth (PTB; <37 weeks), late miscarriage (14-25 weeks), and severe preterm birth (SPTB; 25-35 weeks).

They found that women without AVF in the first trimester have a 75% lower risk for delivery before 35 weeks than women with AVF (odds ratio [OR], 0.26; 95% confidence interval [CI], 0.12-0.56). The absence of lactobacilli increased risk for PTB by almost 2.5 times (OR, 2.4; 95% CI, 1.2-4.8), for early preterm birth (EPTB; <35 weeks) by more than 6 times (OR, 6.2; 95% CI, 2.7-14), and for miscarriage by almost 5 times (OR, 4.9; 95% CI, 1.1-4.7). Coccoid AV increased the risk for EPTB by more than 3 times (OR, 3.2; 95% CI, 1.2-9.1) and for miscarriage by more than 5 times (OR, 5.2; 95% CI, 1.5-17).

Although the presence of Mycoplasma hominis in the study population was rare (1.8%), almost half (43%) of the women with the organisms delivered preterm. Colonization with Ureaplasma urealyticum, group B streptococci, or Candida albicans was not associated with PTB.

Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009;116(10):1315-1324.

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
© 2024 MJH Life Sciences

All rights reserved.